The deregulation of certain oncogenes such as MYCN in neuroblastoma and C-MYC in lymphoma appears to be associated with an increase in single-agent CHK1 sensitivity, possibly through enhanced replication stress. This evidence concerns the gene MYCN and lymphoma.